Savient Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 4 of about 4   

Articles published

SVNTQ 0.0019
price chart
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer
That's been tough, Cautreels says, in part because of the immunogenicity associated with the approach. One company, Bridgewater, NJ-based Savient Pharmaceuticals, won FDA approval of such a drug, called pegloticase (Krystexxa), in 2010. For various ...
Related articles »